Last month, regular folks teamed up to “short squeeze” shares of GameStop higher, forcing hedge funds betting against the stock to slingshot its share price higher as they escaped their losing bets. Now it’s open season on short sellers — and they’re running scared.
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!
Make no mistake – now’s a great time to be a catalyst-focused investor. There’s a lot of anxiety in the market right now. That’s exactly when it pays to be opportunistic.
With GameStop plummeting back to Earth this week, gangs of traders are on the lookout for the next potential squeeze target. That’s what’s driving today’s massive surge in shares your rare disease biotech play...
Just wanted to drop you a quick note today — I’ll save the full-blown update for Thursday… But I just had to let you know that your catalysts are crushing it this week!
We’ve had some good success in the past trading drug catalysts… Now an upcoming COVID-19 catalyst could pull the pin on a profit grenade for one tiny pharma firm.
As expected, no word yet on who’s going to be occupying the White House for the next four years. A little more surprising was the market’s reaction to the fact that Washington gridlock will continue. But the worst could still be yet to come…
A new feature will be coming soon to Catalyst Trader. I anticipate many more big catalyst wins to roll in during the coming weeks and months… But I want to supercharge your gain chances!